SINOPHARM(CNCM LTD)(SH:600511) Sou Hu Cai Jing·2025-12-10 01:09Meeting Attendance and Voting - The shareholder meeting was held on December 9, 2025, at the specified location in Beijing [2] - A total of 778 shareholders and proxies attended the meeting, representing 464,351,992 shares [1][2] - The voting method complied with the Company Law and Articles of Association, with both on-site and online voting conducted [2] Board Meeting Details - The board meeting had 9 directors present, including 4 independent directors, and was chaired by Liu Yuetao [7] - The meeting was convened following proper notification procedures, and all attendees were qualified to participate [4][7] Resolutions Passed - The board approved the adjustment of the specialized committee members with a unanimous vote of 9 in favor [9] - The board also approved an increase in the estimated amount for daily related transactions for 2025, amounting to 85,302.36 million yuan, with independent directors abstaining from the vote [9][15] - The board confirmed the operating performance assessment for 2024, based on audited financial data [10][11] Legal Verification - The meeting was witnessed by Beijing Guofeng Law Firm, which confirmed that the meeting's procedures complied with legal and regulatory requirements [4] Daily Related Transactions - The company plans to increase the estimated amount for daily related transactions for 2025, which is necessary for its operational needs and does not harm the interests of non-related shareholders [14][15] - The total expected amount for new daily related transactions is 85,302.36 million yuan, and the pricing policies are aligned with market principles [16][18]